Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial
Background: Despite recent advances in mobilization techniques, a considerable portion of patients fail to mobilize sufficient number of cells for successful autologous stem cell transplantation. There are several studies available that have demonstrated enhanced mobilization of endothelial progenit...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2016-02-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/468 |
_version_ | 1797760795840348160 |
---|---|
author | Mehdi Mohammadi Mohammad Vaezi Bahram Chahardouli Molouk Hadjibabaie Ardeshir Ghavamzadeh |
author_facet | Mehdi Mohammadi Mohammad Vaezi Bahram Chahardouli Molouk Hadjibabaie Ardeshir Ghavamzadeh |
author_sort | Mehdi Mohammadi |
collection | DOAJ |
description | Background: Despite recent advances in mobilization techniques, a considerable portion of patients fail to mobilize sufficient number of cells for successful autologous stem cell transplantation. There are several studies available that have demonstrated enhanced mobilization of endothelial progenitor cells with atorvastatin. Therefore, this prospective trial was conducted to evaluate the mobilizing effect of atorvastatin on hematopoietic progenitor cells.
Subjects and Methods: Forty-four autologous HSCT candidates were randomized in a double-blind controlled trial to receive atorvastatin 40 mg daily or placebo plus standard G-CSF regimen. Treatment was initiated at the time of hospitalization and continued until the day of cell harvest. Independent-samples T-Test, Repeated Measures ANOVA and Mann-Whitney U test were performed to compare means. Categorical variables were analyzed using Chi-square and Fisher’s exact test.
Results: Mean number of hematopoietic progenitor cells per microL of peripheral blood at the time of cell harvest did not differ significantly between the two groups. There was no statistically significant difference in secondary outcomes like time of platelet or PMN engraftment, occurrence of bleeding or infectious episode, duration of hospitalization and etc.
Conclusion: The results of this study did not support beneficial effects of atorvastatin on mobilization of hematopoietic progenitor cells from bone marrow. |
first_indexed | 2024-03-12T19:04:39Z |
format | Article |
id | doaj.art-d5c388ef242d4c74a85f567c741b1901 |
institution | Directory Open Access Journal |
issn | 2008-2207 |
language | English |
last_indexed | 2024-03-12T19:04:39Z |
publishDate | 2016-02-01 |
publisher | Tehran University of Medical Sciences |
record_format | Article |
series | International Journal of Hematology-Oncology and Stem Cell Research |
spelling | doaj.art-d5c388ef242d4c74a85f567c741b19012023-08-02T06:24:43ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-22072016-02-0194456Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trialMehdi Mohammadi0Mohammad Vaezi1Bahram Chahardouli2Molouk Hadjibabaie3Ardeshir Ghavamzadeh4Clinical Pharmacy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, IranResearch Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran. AND Clinical Pharmacy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, IranBackground: Despite recent advances in mobilization techniques, a considerable portion of patients fail to mobilize sufficient number of cells for successful autologous stem cell transplantation. There are several studies available that have demonstrated enhanced mobilization of endothelial progenitor cells with atorvastatin. Therefore, this prospective trial was conducted to evaluate the mobilizing effect of atorvastatin on hematopoietic progenitor cells. Subjects and Methods: Forty-four autologous HSCT candidates were randomized in a double-blind controlled trial to receive atorvastatin 40 mg daily or placebo plus standard G-CSF regimen. Treatment was initiated at the time of hospitalization and continued until the day of cell harvest. Independent-samples T-Test, Repeated Measures ANOVA and Mann-Whitney U test were performed to compare means. Categorical variables were analyzed using Chi-square and Fisher’s exact test. Results: Mean number of hematopoietic progenitor cells per microL of peripheral blood at the time of cell harvest did not differ significantly between the two groups. There was no statistically significant difference in secondary outcomes like time of platelet or PMN engraftment, occurrence of bleeding or infectious episode, duration of hospitalization and etc. Conclusion: The results of this study did not support beneficial effects of atorvastatin on mobilization of hematopoietic progenitor cells from bone marrow.https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/468AtorvastatinAutologousHSCTMobilization |
spellingShingle | Mehdi Mohammadi Mohammad Vaezi Bahram Chahardouli Molouk Hadjibabaie Ardeshir Ghavamzadeh Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial International Journal of Hematology-Oncology and Stem Cell Research Atorvastatin Autologous HSCT Mobilization |
title | Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial |
title_full | Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial |
title_fullStr | Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial |
title_full_unstemmed | Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial |
title_short | Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial |
title_sort | effects of short term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells a double blind randomized controlled trial |
topic | Atorvastatin Autologous HSCT Mobilization |
url | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/468 |
work_keys_str_mv | AT mehdimohammadi effectsofshorttermpretreatmentwithatorvastatinonmobilizationofhematopoieticprogenitorcellsadoubleblindrandomizedcontrolledtrial AT mohammadvaezi effectsofshorttermpretreatmentwithatorvastatinonmobilizationofhematopoieticprogenitorcellsadoubleblindrandomizedcontrolledtrial AT bahramchahardouli effectsofshorttermpretreatmentwithatorvastatinonmobilizationofhematopoieticprogenitorcellsadoubleblindrandomizedcontrolledtrial AT moloukhadjibabaie effectsofshorttermpretreatmentwithatorvastatinonmobilizationofhematopoieticprogenitorcellsadoubleblindrandomizedcontrolledtrial AT ardeshirghavamzadeh effectsofshorttermpretreatmentwithatorvastatinonmobilizationofhematopoieticprogenitorcellsadoubleblindrandomizedcontrolledtrial |